Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1953 1
1954 1
1955 1
1956 3
1958 3
1960 2
1962 2
1963 1
1964 6
1965 4
1966 3
1967 6
1968 3
1969 3
1970 1
1971 3
1973 2
1974 3
1975 3
1976 3
1977 1
1978 3
1979 3
1980 3
1981 3
1982 3
1983 1
1985 2
1986 5
1987 2
1988 13
1989 4
1990 3
1991 11
1992 3
1993 4
1994 9
1995 5
1996 4
1997 14
1998 10
1999 10
2000 12
2001 7
2002 9
2003 3
2004 5
2005 3
2006 1
2007 1
2008 3
2009 6
2010 8
2011 5
2012 2
2013 3
2014 9
2015 6
2016 6
2017 4
2018 1
2019 3
2020 8
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

271 results
Results by year
Filters applied: . Clear all
Page 1
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT Chronic Migraine Study Group. Dodick DW, et al. Among authors: brin mf. Headache. 2010 Jun;50(6):921-36. doi: 10.1111/j.1526-4610.2010.01678.x. Epub 2010 May 7. Headache. 2010. PMID: 20487038 Clinical Trial.
Pregnancy outcomes following exposure to onabotulinumtoxinA.
Brin MF, Kirby RS, Slavotinek A, Miller-Messana MA, Parker L, Yushmanova I, Yang H. Brin MF, et al. Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):179-87. doi: 10.1002/pds.3920. Epub 2015 Dec 4. Pharmacoepidemiol Drug Saf. 2016. PMID: 26635276 Free PMC article.
271 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page